• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group.

作者信息

de Wit P E, van't Hof-Grootenboer B, Ruiter D J, Bondi R, Bröcker E B, Cesarini J P, Hastrup N, Hou-Jensen K, MacKie R M, Scheffer E

机构信息

Institute of Pathology, University Hospital Nijmegen, The Netherlands.

出版信息

Eur J Cancer. 1993;29A(6):831-9. doi: 10.1016/s0959-8049(05)80419-8.

DOI:10.1016/s0959-8049(05)80419-8
PMID:8484972
Abstract

Ten (dermato)pathologists studied 50 cutaneous melanocytic lesions including common naevocellular naevi, dysplastic naevi (DN), melanomas in situ and invasive primary melanomas, with emphasis on the histological criteria of DN. Using a standardised form, 20 defined histopathological features were scored (semi)quantitatively. Concordance of diagnosis, efficacy and reproducibility of features were investigated. DN were distinguished well from the other entities (mean Po 0.87). Agreement on the degree of atypia of DN was low. The reproducibility of the scoring was best for the following features: irregular nests, lymphohistiocytic infiltrate, marked junctional proliferation and large nuclei. The overall values of these features to discriminate between DN and non-DN were better than for the other features studied. Using the presence of at least three of the four features as a condition for the diagnosis of DN, values for sensitivity, specificity and positive and negative predictive values were 0.86, 0.91, 0.96 and 0.73, respectively. On the basis of the results these features seem best suited as histological criteria for the diagnosis of DN.

摘要

相似文献

1
Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group.
Eur J Cancer. 1993;29A(6):831-9. doi: 10.1016/s0959-8049(05)80419-8.
2
The efficacy of histopathological criteria required for diagnosing dysplastic naevi.
Histopathology. 1988 Mar;12(3):289-300. doi: 10.1111/j.1365-2559.1988.tb01943.x.
3
The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.发育异常痣的超微结构:与浅表扩散性黑素瘤和普通痣细胞痣的比较。
Arch Dermatol Res. 1990;282(6):353-62. doi: 10.1007/BF00372084.
4
The usefulness of single and combined clinical characteristics for the diagnosis of dysplastic naevi.单一及联合临床特征对发育异常痣诊断的有用性。
Melanoma Res. 1992 Jan-Feb;1(5-6):377-83. doi: 10.1097/00008390-199201000-00009.
5
[Dysplastic nevus in differential epiluminescence microscopy diagnosis of melanoma].[发育异常痣在黑色素瘤表皮透光显微镜鉴别诊断中的作用]
Hautarzt. 1996 Feb;47(2):109-13. doi: 10.1007/s001050050386.
6
Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.发育异常痣与原位黑色素瘤:数字皮肤镜分析
Br J Dermatol. 2005 Apr;152(4):679-84. doi: 10.1111/j.1365-2133.2005.06481.x.
7
A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.下肢远端(脚踝)的一部分黑素细胞痣具有肢端痣、发育异常痣和原位黑素瘤的特征:可能会被误诊为原位黑素瘤。
Am J Surg Pathol. 2007 Jul;31(7):1130-6. doi: 10.1097/PAS.0b013e31802e63a2.
8
Histopathologic reassessment of melanoma and other melanocytic skin lesions excised in 2009 and 2018-2019.2009 年和 2018-2019 年切除的黑色素瘤和其他黑素细胞性皮肤病变的组织病理学再评估。
Tidsskr Nor Laegeforen. 2022 Oct 24;142(15). doi: 10.4045/tidsskr.22.0204. Print 2022 Oct 25.
9
Dysplastic naevi--an alternative view.发育异常痣——另一种观点。
Histopathology. 1990 Jan;16(1):29-35. doi: 10.1111/j.1365-2559.1990.tb01056.x.
10
Dysplastic nevus: Fact and fiction.发育不良性痣:事实与虚构。
J Am Acad Dermatol. 2015 Sep;73(3):507-12. doi: 10.1016/j.jaad.2015.04.029. Epub 2015 May 30.

引用本文的文献

1
Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.四色荧光原位杂交有助于辅助区分早期肢端和皮肤黑素瘤与异型性交界痣或复合痣。
Diagn Pathol. 2020 May 11;15(1):51. doi: 10.1186/s13000-020-00937-9.
2
Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis.口腔颌面区域的癌前病变:一篇特别关注病因发病机制的文献综述
Iran J Pathol. 2016 Fall;11(4):303-322.
3
From melanocytes to melanomas.
从黑素细胞到黑色素瘤。
Nat Rev Cancer. 2016 Jun;16(6):345-58. doi: 10.1038/nrc.2016.37. Epub 2016 Apr 29.
4
NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.黑色素瘤相关痣和未受累痣中的NRAS 和 BRAF 突变。
PLoS One. 2013 Jul 8;8(7):e69639. doi: 10.1371/journal.pone.0069639. Print 2013.
5
Dysplastic nevi and melanoma.发育不良痣和黑色素瘤。
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):528-32. doi: 10.1158/1055-9965.EPI-12-1346.
6
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.发育不良性痣:从历史角度到现代时代的管理:第一部分。历史、组织学和临床方面。
J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047.
7
Interobserver reproducibility of histological features in cutaneous malignant melanoma.皮肤恶性黑色素瘤组织学特征的观察者间可重复性
J Clin Pathol. 2005 Nov;58(11):1194-8. doi: 10.1136/jcp.2005.026765.
8
Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic naevi.用于诊断黑色素瘤的组织学特征在良性黑素细胞痣中也很常见。
J Clin Pathol. 2005 Apr;58(4):409-12. doi: 10.1136/jcp.2004.020933.
9
The dysplastic naevus.发育异常痣。
J Clin Pathol. 1997 Sep;50(9):711-5. doi: 10.1136/jcp.50.9.711.
10
A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.一项关于薄皮恶性黑色素瘤诊断中观察者变异的全国性调查,包括MIN术语。结直肠癌黑色素瘤病理小组。
J Clin Pathol. 1997 Mar;50(3):202-5. doi: 10.1136/jcp.50.3.202.